SEDATIVE HYPNOTICS EMPLOYED TO TREAT PATIENTS WITH AND WITHOUT INSOMNIA COMPLAINTS IN THE NATIONAL AMBULATORY MEDICAL CARE SURVEY- 1997-2002
Author(s)
Tan LSM, Morlock RPifzer Inc, Ann Arbor, MI, USA
OBJECTIVES: Pharmaceutical treatments are available for patients with a complaint of insomnia. These treatments often vary by patient and physician characteristics. This study describes the use of several medications commonly used to treat sleep disorders as reported in the National Ambulatory Medical Care Survey (NAMCS). METHODS: Data was obtained from the SIX years of NAMCS data (1997 through 2002). Analyses were utilized to examine medications (ie., triazolam, temazepam, flurazepam, zolpidem or zaleplon, trazadone, and diphenhydramine) commonly used to treat individuals with a complaint of insomnia. Patient level weights were utilized to derive US national population estimates. Given the complex stratified survey design, Rao Scott and Wald Chi-square tests were used to assess statistically significant differences within groups. RESULTS: For all patients taking a medication commonly used to treat sleep complaints, psychiatrists were more likely to prescribe trazadone (54%), while family/general practice physicians (29%), general internists (35%) and other specialists (28) were more likely to prescribe zolpidem or zaleplon. Those 65 years and older were more likely to be prescribed zolpidem or zaleplon (30%) and younger patients were most often prescribed trazadone (70%). CONCLUSION: Newer sleep agents such as zolpidem or zaleplon are the most commonly prescribed medication across the majority of physician-types. This study provides an important descriptive look at those who are taking medications commonly used to treat sleep disorders.
Conference/Value in Health Info
2005-05, ISPOR 2005, Washington, DC, USA
Value in Health, Vol. 8, No. 3 (May/June 2005)
Code
PNL34
Topic
Real World Data & Information Systems
Topic Subcategory
Health & Insurance Records Systems
Disease
Neurological Disorders